Cancer-related inflammation and treatment effectiveness

被引:1878
作者
Diakos, Connie I. [1 ]
Charles, Kellie A. [2 ]
McMillan, Donald C. [3 ]
Clarke, Stephen J. [1 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[3] Univ Glasgow, Royal Infirm, Sch Med, Acad Surg Unit, Glasgow, Lanark, Scotland
关键词
C-REACTIVE PROTEIN; NF-KAPPA-B; COLORECTAL-CANCER; SUPPRESSOR-CELLS; PROGNOSTIC VALUE; TUMOR NECROSIS; LYMPHOCYTE RATIO; MYELOID CELLS; THERAPY; SURVIVAL;
D O I
10.1016/S1470-2045(14)70263-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inflammation is a recognised hallmark of cancer that substantially contributes to the development and progression of malignancies. In established cancers, there is increasing evidence for the roles that local immune response and systemic inflammation have in progression of tumours and survival of patients with cancer. This knowledge provides an opportunity to target these inflammatory responses to improve patient outcomes. In this Review, we examine the complex interplay between local immune responses and systemic inflammation, and their influence on clinical outcomes, and propose potential anti-inflammatory interventions for patients with cancer.
引用
收藏
页码:E493 / E503
页数:11
相关论文
共 92 条
[11]   Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer [J].
Chua, W. ;
Charles, K. A. ;
Baracos, V. E. ;
Clarke, S. J. .
BRITISH JOURNAL OF CANCER, 2011, 104 (08) :1288-1295
[12]   Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer [J].
Coward, Jermaine ;
Kulbe, Hagen ;
Chakravarty, Probir ;
Leader, David ;
Vassileva, Vessela ;
Leinster, D. Andrew ;
Thompson, Richard ;
Schioppa, Tiziana ;
Nemeth, Jeffery ;
Vermeulen, Jessica ;
Singh, Naveena ;
Avril, Norbert ;
Cummings, Jeff ;
Rexhepaj, Elton ;
Jirstrom, Karin ;
Gallagher, William M. ;
Brennan, Donal J. ;
McNeish, Iain A. ;
Balkwill, Frances R. .
CLINICAL CANCER RESEARCH, 2011, 17 (18) :6083-6096
[13]   Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy [J].
Diaz-Montero, C. Marcela ;
Salem, Mohamed Labib ;
Nishimura, Michael I. ;
Garrett-Mayer, Elizabeth ;
Cole, David J. ;
Montero, Alberto J. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) :49-59
[14]   NF-κB and the link between inflammation and cancer [J].
DiDonato, Joseph A. ;
Mercurio, Frank ;
Karin, Michael .
IMMUNOLOGICAL REVIEWS, 2012, 246 :379-400
[15]   Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives [J].
Dieci, Maria Vittoria ;
Arnedos, Monica ;
Andre, Fabrice ;
Soria, Jean Charles .
CANCER DISCOVERY, 2013, 3 (03) :264-279
[16]  
Fagard Remi, 2013, JAKSTAT, V2, pe22882, DOI 10.4161/jkst.22882
[17]   PATHOLOGICAL FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST PROJECT (PROTOCOL NO 4) .4. SIGNIFICANCE OF TUMOR NECROSIS [J].
FISHER, ER ;
PALEKAR, AS ;
GREGORIO, RM ;
REDMOND, C ;
FISHER, B .
HUMAN PATHOLOGY, 1978, 9 (05) :523-530
[18]   Neutrophil: Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery [J].
Forget, Patrice ;
Machiels, Jean-Pascal ;
Coulie, Pierre G. ;
Berliere, Martine ;
Poncelet, Alain J. ;
Tombal, Bertrand ;
Stainier, Annabelle ;
Legrand, Catherine ;
Canon, Jean-Luc ;
Kremer, Yann ;
De Kock, Marc .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 :S650-S660
[19]   An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score [J].
Frank, I ;
Blute, ML ;
Cheville, JC ;
Lohse, CM ;
Weaver, AL ;
Zincke, H .
JOURNAL OF UROLOGY, 2002, 168 (06) :2395-2400
[20]   Coordinated regulation of myeloid cells by tumours [J].
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Bronte, Vincenzo .
NATURE REVIEWS IMMUNOLOGY, 2012, 12 (04) :253-268